116074 ⎘
Transferases transferring phosphorus-containing groups (2.7); Protein-serine/threonine kinases (2.7.11) Polo kinase (2.7.11.21)
Enhanced expression of polo-like kinase 3 (PLK3) in human immunodeficiency virus (HIV)-infected cells
#2PLK1 TARGET PHOSPHORYLATION STATUS AND TREATMENT OF CANCER WITH PLK1 INHIBITORS
#3HLA-A2 subtype-specific PLK1-derived epitope inducing antigen-specific t cell immune response to PLK1 protein
#4Peptides derived from NCAPG2 and their use
#5Peptides derived from NCAPG2 and their use
#6Small interference RNAs, uses thereof and method for inhibiting the expression of PLK1 gene
#7Sphingolipid-polyalkylamine-oligonucleotide compounds
#8Method of Forming Fragment Ligated Inhibitors
#9Fragment ligated inhibitors selective for the polo box domain of PLK1
#10Therapeutics with conformationally restricted monomers
#11Small interference RNAs, uses thereof and method for inhibiting the expression of plk1 gene
#12Peptide mimetic ligands of polo-like kinase 1 polo box domain and methods of use
#13Tumor antigen proteins or genes of polo-like kinase 1
#14Fragment ligated inhibitors selective for the polo box domain of PLK1
#15Alpha-synuclein kinase
#16Silencing of polo-like kinase expression using interfering RNA
#17Alpha-Synuclein Kinase
#18Alpha-synuclein kinase